1. Home
  2. AMPH vs HDL Comparison

AMPH vs HDL Comparison

Compare AMPH & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • HDL
  • Stock Information
  • Founded
  • AMPH 1996
  • HDL 2016
  • Country
  • AMPH United States
  • HDL Singapore
  • Employees
  • AMPH N/A
  • HDL N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • HDL Restaurants
  • Sector
  • AMPH Health Care
  • HDL Consumer Discretionary
  • Exchange
  • AMPH Nasdaq
  • HDL Nasdaq
  • Market Cap
  • AMPH 1.1B
  • HDL 1.2B
  • IPO Year
  • AMPH 2014
  • HDL 2024
  • Fundamental
  • Price
  • AMPH $21.21
  • HDL $19.13
  • Analyst Decision
  • AMPH Hold
  • HDL
  • Analyst Count
  • AMPH 5
  • HDL 0
  • Target Price
  • AMPH $38.00
  • HDL N/A
  • AVG Volume (30 Days)
  • AMPH 476.8K
  • HDL 4.1K
  • Earning Date
  • AMPH 08-07-2025
  • HDL 08-26-2025
  • Dividend Yield
  • AMPH N/A
  • HDL N/A
  • EPS Growth
  • AMPH N/A
  • HDL 110.82
  • EPS
  • AMPH 2.77
  • HDL 0.06
  • Revenue
  • AMPH $730,659,000.00
  • HDL $789,766,000.00
  • Revenue This Year
  • AMPH $0.92
  • HDL $14.91
  • Revenue Next Year
  • AMPH $5.55
  • HDL $12.41
  • P/E Ratio
  • AMPH $7.67
  • HDL $33.23
  • Revenue Growth
  • AMPH 8.05
  • HDL 10.91
  • 52 Week Low
  • AMPH $20.39
  • HDL $13.94
  • 52 Week High
  • AMPH $53.96
  • HDL $30.00
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 39.13
  • HDL N/A
  • Support Level
  • AMPH $20.43
  • HDL N/A
  • Resistance Level
  • AMPH $22.90
  • HDL N/A
  • Average True Range (ATR)
  • AMPH 0.74
  • HDL 0.00
  • MACD
  • AMPH 0.05
  • HDL 0.00
  • Stochastic Oscillator
  • AMPH 32.80
  • HDL 0.00

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.

Share on Social Networks: